Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices 39765 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Neuroscience Review 

Subcommittee. 

Date: October 19, 2018. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700–B Rockledge Drive, 

Conference Rooms A & B, Bethesda, MD 

20817. 

Contact Person: Beata Buzas, Ph.D., 

Scientific Review Officer, Office of 

Extramural Activities, National Institute on 

Alcohol Abuse and Alcoholism, 6700–B 

Rockledge Drive, Room 2116, Bethesda, MD 

20892, 301–443–0800, bbuzas@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: August 6, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–17105 Filed 8–9–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute Amended; 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Advisory Board, August 14, 2018, 1:00 

p.m. to August 14, 2018, 4:00 p.m., 

National Cancer Institute Shady Grove, 

9609 Medical Center Drive, Conference 

Room TE406, Rockville, MD 20850 

which was published in the Federal 

Register on August 02, 2018, 83 FR 

37820. 

The meeting notice is being amended 

to change the meeting times for the open 

and closed sessions. The open session 

will be held from 1:00 p.m. to 3:45 p.m. 

The closed session will be held from 

3:50 p.m. to 4:30 p.m. The meeting is 

partially closed to the public. 

Dated: August 6, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–17104 Filed 8–9–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer at (240) 276– 

1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: State Targeted 

Response to the Opioid Crisis Grant 

Program Mid-Year and End-Year 

Performance Reports 

(OMB No. 0930–0378)—In Use Without 

OMB Approval 

The Substance Abuse and Mental 

Health Services Administration 

(SAMHSA) is authorized under Section 

1003 of the 21st Century Cures Act, as 

amended, to support a grant program, 

for up to 2 years, that addresses the 

supplemental activities pertaining to 

opioids currently undertaken by the 

state agency or territory and will 

support a comprehensive response to 

the opioid epidemic. 

SAMHSA received approval from 

OMB in September 2017 to collect 

performance data from Opioid State 

Targeted Response (STR) grantees (OMB 

No. 0930–0378). However, SAMHSA 

omitted a data collection table (Table E) 

in the original OMB request. This data 

table is currently in use by Opioid STR 

grantees, who are reporting Table E data 

to SAMHSA on a semi-annual basis. In 

order to correct this violation, SAMHSA 

is now seeking OMB approval for a new 

data collection package that includes 

not only the instruments originally 

approved by OMB in September 2017, 

but also this additional data collection 

table. It is important for SAMHSA to 

continue to collect this information in 

order to assess the impact of funding 

from the Opioid STR program on 

increasing access to prevention 

strategies, as well as treatment and 

recovery services to address the opioid 

crisis. Additionally, this data will 

provide SAMHSA with critical 

information to effectively manage the 

Opioid STR program, to help states and 

territories adopt, or scale-up, effective 

practices and policies, and to help 

prepare to implement the new State 

Opioid Response grant program. 

The primary purpose of the Opioid 

STR program is to address the opioid 

crisis by increasing access to treatment, 

reducing unmet treatment need, and 

reducing opioid overdose related deaths 

through the provision of prevention, 

treatment and recovery activities for 

opioid use disorder (OUD) (including 

prescription opioids as well as illicit 

drugs such as heroin). 

There are 57 (states and jurisdictions) 

award recipients in this program. All 

funded states and jurisdictions report on 

their implementation and performance 

through an online data collection 

system. Award recipients report 

performance on the following measures 

specific to this program: number of 

people who receive OUD treatment, 

number of people who receive OUD 

recovery services, number of providers 

implementing medication-assisted 

treatment, and the number of OUD 

prevention and treatment providers 

trained, to include nurse practitioners, 

physician assistants, as well as 

physicians, nurses, counselors, social 

workers, case managers, etc. This 

information is collected at the mid-point 

and conclusion of each grant award 

year. Additionally, each award recipient 

describes the purposes for which the 

grant funds received were expended and 

the activities implemented under the 

program. 


daltland on DSKBBV9HB2PROD with NOTICES